Recruiting Observational NCT04562012

Lateral Flow Assays for Pathogens of the Plague (SMARTPRT)

Point of Care Diagnostic to Identify the Causative Agent of the Plague

Sponsor: Brimrose Technology Corporation

Conditions Bubo; Yersinia Pestis Bubonic; Plague, Skin Plague Plague, Bubonic Plague, Pneumonic Pneumonic Plague Yersinia Pestis Infection Yersinia Pestis Plague Yersinia Pestis; Bubo Yersinia Pestis; Pneumonia Yersinia Sepsis

Interventions Lateral Flow Assay for Pathogens of the Plague

Updated 4 times since 2020 Last updated: Nov 12, 2020 Started: Oct 19, 2020 Primary completion: Jul 31, 2022 Completion: Nov 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04562012, this observational or N/A phase trial focuses on Bubo; Yersinia Pestis and Bubonic; Plague, Skin and remains actively recruiting participants. Sponsored by Brimrose Technology Corporation, it has been updated 4 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Jan 2021 — Present [monthly]

Recruiting
Dec 2020 — Jan 2021 [monthly]

Recruiting
Nov 2020 — Dec 2020 [monthly]

Recruiting
Oct 2020 — Nov 2020 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brimrose Technology Corporation
Institut Pasteur de Madagascar
Naval Health Research Center
New Horizons Diagnostics Corporation
Northern Arizona University

Data source: Brimrose Technology Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Antananarivo, Madagascar